SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-19-026477
Filing Date
2019-12-18
Accepted
2019-12-18 17:25:25
Documents
7
Period of Report
2019-10-04
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO CURRENT REPORT f8k100419a1_optimizerxcorp.htm 8-K/A 31262
2 CONSENT OF INDEPENDENT ACCOUNTANTS f8k100419a1ex23-1_optimizerx.htm EX-23.1 4319
3 AUDITED FINANCIAL STATEMENTS FOR RMDY f8k100419a1ex99-1_optimizerx.htm EX-99.1 194223
4 UNAUDITED FINANCIAL STATEMENTS FOR RMDY f8k100419a1ex99-2_optimizerx.htm EX-99.2 112687
5 f8k100419a1ex99-3_optimizerx.htm EX-99.3 187855
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5017
7 GRAPHIC ex99-1_002.jpg GRAPHIC 6253
  Complete submission text file 0001213900-19-026477.txt   547383
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38543 | Film No.: 191293360
SIC: 7389 Services-Business Services, NEC